Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Camp4 Therapeutics (CAMP) Interest Expenses (2023 - 2024)

Camp4 Therapeutics' Interest Expenses history spans 2 years, with the latest figure at -$145000.0 for Q4 2024.

  • On a quarterly basis, Interest Expenses fell 274.7% to -$145000.0 in Q4 2024 year-over-year; TTM through Sep 2025 was -$145000.0, a 200.0% decrease, with the full-year FY2025 number at $192000.0, up 481.82% from a year prior.
  • Interest Expenses hit -$145000.0 in Q4 2024 for Camp4 Therapeutics, down from $62000.0 in the prior quarter.
  • Over the last five years, Interest Expenses for CAMP hit a ceiling of $83000.0 in Q4 2023 and a floor of -$145000.0 in Q4 2024.